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Summary 
We report outcomes from an EPAG-led cross-industry study, characterizing flow rate/elapsed-time profiles of 
equipment used for testing dry powder inhalers (DPIs). A thermal mass flow sensor was used by nine organizations 
in a round-robin approach to record inlet flow rate-time profiles of individual participant compendial test systems 
(TS) including either sample collection tubes (SCT) or a cascade impactor (either the Andersen 8-stage non-viable 
impactor, ACI, or the Next Generation Impactor, NGI) equipped with USP/PhEur induction port and pre-separator. 
An inlet orifice generated a 4-kPa pressure drop at each of the target flow rates (30, 60 and 90 L/min), simulating a 
pressure drop typical for high-, medium- and low-resistance DPIs respectively. Rise times to 90% of these target 
flow rates (t90) were longest with largest internal dead volume and followed the order NGI>ACI >SCT>TS. When 
the surrogate DPI (4-kPa orifice) was absent, t90 values generally lengthened with increasing target flow rate.  In 
contrast, the opposite behaviour was observed when the surrogate DPI was present.  A flow acceleration parameter 
was also calculated, expressed as the slope between the 20% and 80% flow rates of each final steady flow value 
(slopet20/t80).  Greater flow acceleration occurred at higher final flow rates, irrespective of apparatus, but the 
presence of the surrogate DPI was associated with slower flow acceleration. These flow rate-rise time profiles will 
be useful for those involved in evaluating equipment for characterizing both existing and new DPIs.  
Key Message 
Flow rate rise times associated with DPI testing are correlated with the magnitude of the internal dead-volume and 
intrinsic resistance of the measurement apparatus. The resistance associated with a surrogate DPI has a marked 
influence on profile shape. These data will prove useful for evaluating and using DPI testing equipment.  
Introduction 
Compendial methods for testing DPIs require the rapid opening of a solenoid valve to start drawing air into and 
through the inhaler at the start of the test1. The flow-rate/rise-time profile has the potential to affect the measured 
in vitro characteristics of the dose that comes from the DPI, as the aerosol formation and subsequent transport of 
the bolus to the measurement apparatus takes place from the inhaler during this period. Furthemore, the cut-point 
sizes of the impactor stages are flow rate dependent. The objectives of the present multi-laboratory investigation 
were therefore as follows: 
1. to measure the influence of DPI resistance on flow-elapsed time profiles for a wide range of equipment 
used in the industry for DPI testing either for content uniformity or emitted aerosol APSD, following 
compendial procedures: 
a. without any resistance at the entry to the measurement apparatus (baseline condition); 
b. with resistance imposed by placing an orifice at the inlet of the apparatus whose aperture was sized 
to mimic a high-, medium- or low-resistance DPI by generating a pressure drop of approximately 4- 
kPa at the chosen target final flow rates of 30, 60 and 90 L/min respectively. 
2. to define and report the following measures of the flow-time profile that are believed to be helpful to the 
user community:  
a. the area under the flow rate-time profile (AUC), equivalent to the sampled volume;  
b. the associated time for the flow rate to achieve 90% of the final steady-state flow rate value, t90;  
c. a flow acceleration parameter derived from the slope of the rising flow rate profile, calculated by linear 
interpolation between the times where the flow rate attained 20% and 80% of the final flow rate values 
(slopet20/t80); 
d. the presence of any peak in the flow profile (Qpeak) before reaching the steady-state flow rate; 
Preliminary outcomes from this investigation were reported previously2. Since then, further examination of the data 
has been undertaken, including the exclusion of measurements made by a participant not evaluating DPI products, 
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and repeating tests that had produced anomalous results. The present evaluation therefore reflects a more accurate 
assessment of the flow rate-rise time profiles as an ensemble. The interpretation has been extended by comparing 
the outcomes with internal dead volume (Vint) of the apparatuses, which is the apparatus-specific parameter deemed 
most likely to be correlated with the above metrics. 
Materials and Methods 
The procedures associated with this investigation were previously described2, so only a brief outline is given here. 
A series of flow rate profiles (n = 3 replicates at each condition per apparatus configuration) was therefore 
determined in a round-robin approach by each participating laboratory, using the same calibrated, high-resolution 
(±2% of actual reading) thermal mass flow sensor (model 4040, TSI Corp, Shoreview, MN, USA) located at the inlet 
of each of the following sampling apparatuses, including induction port and pre-separator: 
a. individual participant flow rate test systems (TS) - average Vint = 87 mL; 
b. sample collection tubes (SCT) - average Vint = 115 mL;  
c. an Andersen 8-stage non-viable impactor (ACI) - Vint = 1155 mL3; 
d. a Next Generation Impactor (NGI) - Vint = 2025 mL3. 
The target sample volumes corresponding to the three final flow rates of 30 L/min, 60 L/min and 90 L/min were 2.0 
L, 4.0 L and 6.0 L respectively, assuming an ideal rectangular flow-time profile for the 4.0-s time period of each 
measurement sequence. Flow rate-elapsed time profiles (n=3 replicates) were initially determined at each target 
flow rate, with the inlet to each apparatus fully unrestricted (i.e. open). The measurement sequence was 
subsequently repeated with an orifice-based flow restriction (surrogate DPI). This restriction, when fitted to the inlet 
of each apparatus, applied a fixed 4-kPa pressure drop to simulate either a high-, medium- or low-resistance DPI 
at the final flow rates of 30, 60 and 90 L/min respectively, by adjusting the size of the orifice aperture. The signal 
from the flow sensor was processed for flow-time data recording by a purpose-developed proprietary recording 
software (FlowMonitor version 1.2, Sofotec GmbH, Germany), that is based on the LabVIEWTM platform (National 
Instruments Corp., Austin, TX, USA). Each participant recorded the instantaneous flow rate once every five 
milliseconds.  The recording software stored the flow-time raw data in csv-text file format and performed the 
following calculations: 
a. integration of the resulting flow rate-elapsed time profile to enable the total volume sampled to be 
calculated as the area-under-the-curve (AUC); 
b. determination of the maximum peak flow rate (Qpeak) from the entire flow rate-time profile for that particular 
measurement sequence. 
The following calculations were undertaken subsequently using the collected data for each measurement: 
a. determination of characteristic rise time indicators in milliseconds, t20, t80 and t90, corresponding to times 
to attain 20%, 80%, and 90% of the final steady-state reference flow level respectively.  
b. determination of the slope of the rising flow rate (L/min/ms) by linear interpolation between t20 and t80, to 
evaluate a flow acceleration metric in the middle of the flow rate-time profile (slopet20/t80).  
Results 
Sampled air volumes (AUC) with or without the surrogate DPI were all close to the nominal values of 2.0 L, 4.0 L 
and 6.0 L, with most data within the ±5% interval for all apparatus configurations. The overall associated measures 
of variability (RSD) were low at 1.7%, 1.3% and 2.0% for target flow rates of 30 L/min, 60 L/min, and 90 L/min, 
respectively, confirming that a high degree of measurement accuracy and precision existed overall.   
 
A few values of Qpeak greater than 110% of the targeted flow rate (overshoot) were observed at all target flow rates. 
However, these incidences were confined almost exclusively to the measurements with TS alone (with no SCT nor 
impactor).  The phenomenon was most apparent at the highest flow rate (Figure 1). 
 
At each target rate, values of t90 lengthened as the internal volume of the test setup increased when the surrogate 
DPI was present (Table 1).  The NGI, having the largest Vint, in combination with the surrogate DPI having the 
highest intrinsic resistance (lowest target flow rate), was associated with the longest t90 values at each target flow 
rate. This cascade impactor was also associated with the greatest change in t90 when the target flow rate was 
increased from either 30 to 60 L/min or from 60 to 90 L/min.  Significantly, when the surrogate inhaler was present, 
the opposite behaviour was evident for the t90 values associated with all sampling configurations; that is, t90% 
decreased as the final flow rate was increased. The presence of the surrogate DPI at the inlet also significantly 
increased the t90 values associated with each apparatus compared with corresponding values when that flow 
restriction was absent. 
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Figure 1 - Participant-by-Participant Measures of Qpeak for target flow rate of 90 L/min, Organized by 
Identity Letter Code A to J; TS= Organization-Specific Test System; SCT = Sample Collection Tube; ACI = 
Andersen 8-Stage Cascade Impactor; NGI = Next Generation Impactor 
Longer rise times, in combination with decreased values of the flow acceleration parameter (Table 2), were 
associated with apparatus configurations having larger internal volumes.  This behaviour is best illustrated by the 
data for the NGI, whose internal volume with pre-separator is almost twice that of the ACI with pre-separator. 
 
Table 1 - Mean Values of t90 for Each Apparatus  
 
Surrogate 
DPI 
Apparatus 
Configuration 
Average Vint 
(mL) 
Final Flow 
Rate = 30 
L/min 
Final Flow 
Rate = 60 
L/min 
Final Flow 
Rate = 90 
L/min 
t90 (ms) 
Absent 
TS 87 12 (n=45) 
13 
(n=45) 
13 
(n=44) 
SCT 115 33 (n=27) 
34 
(n=27) 
34 
(n=27) 
ACI 60 L/min* + 
preseparator 1155 
32 
(n=9) 
46 
(n=12) 
65 
(n=9) 
NGI  
+ preseparator 2025 
49 
(n=27) 
91 
(n=27) 
106 
(n=27) 
Present 
TS 87 31 (n=45) 
20 
(n=45) 
17 
(n=45) 
SCT 115 62 (n=27) 
46 
(n=27) 
41 
(n=27) 
ACI 60 L/min* + 
preseparator 1155 
281 
(n=9) 
158 
(n=12) 
131 
(n=9) 
NGI  
+ preseparator 2025 
431 
(n=27) 
266 
(n=27) 
197 
(n=27) 
* ACI 60 L/min stage configuration: stages -1, -0, 1 to 6, and back-up filter 
 
Drug Delivery to the Lungs (DDL2018), 2018 - A European Pharmaceutical Aerosol Group (EPAG)-Led Cross-
Industry Assessment of Inlet Flow Rate Profiles of Compendial DPI Test Systems: Part 1 – Experimental Data 
 Table 2:  
  
Surrogate 
DPI 
Apparatus 
Configuration 
Average Vint 
(mL) 
Final Flow 
Rate = 30 
L/min 
Final Flow 
Rate = 60 
L/min 
Final Flow 
Rate = 90 
L/min 
Slopet20 / t80  (L/min/ms) 
Absent 
TS 87 3.72 (n=45) 
7.15 
(n=45) 
10.30 
(n=44) 
SCT 115 2.37 (n=27) 
4.59 
(n=27) 
6.84 
(n=27) 
ACI 60 L/min*+ 
preseparator 1155 
1.83 
(n=9) 
2.18 
(n=12) 
2.00 
(n=9) 
NGI  
+ preseparator 2025 
1.74 
(n=27) 
0.98 
(n=27) 
1.14 
(n=27) 
Present 
TS 87 1.67 (n=45) 
4.42 
(n=45) 
8.46 
(n=45) 
SCT 115 0.85 (n=27) 
2.96 
(n=27) 
4.87 
(n=27) 
ACI 60 L/min*+ 
preseparator 1155 
0.14 
(n=9) 
0.49 
(n=12) 
0.88 
(n=9) 
NGI  
+ preseparator 2025 
0.08 
(n=27) 
0.27 
(n=27) 
0.54 
(n=27) 
* ACI 60 L/min stage configuration: stages -1, -0, 1 to 6, and back-up filter 
Discussion and Conclusion:  
Rise time performance, both with and without the surrogate DPI present, was relatively undamped for either the TS 
or SCT apparatuses (where both Vint and intrinsic apparatus resistance were small), reflected in short t90 and large 
slopet20/t80 values. This behaviour was largely independent of whether the surrogate DPI was present or absent. 
The increased resistance imposed by the surrogate DPI resulted in slower rise times and reduced slopet20/t80 values. 
This behaviour was evident with all apparatus configurations, but was most apparent with both the CIs, that had 
substantially larger values of Vint.  
The greatly dampened flow rate rise time behaviour with these apparatuses requires further explanation, as does 
the reversal in the behaviour of the relationships between both rise time and slope and target flow rate for a given 
apparatus configuration, comparing the situations when the surrogate DPI was absent or present. The first few 
stages of either CI comprise at least half, if not more, of the total internal dead volume, and contribute only a small 
flow resistance compared to that imposed by the presence of the 4-kPa pressure drop associated with the surrogate 
device. When the surrogate DPI was absent, the CI volume encompassing these low-resistance stages filled up 
relatively rapidly, so that the magnitude of t90 was dictated almost exclusively by the resistance of the last one or 
two stages having the highest intrinsic resistance.  When the 4-kPa surrogate device was present, however, the air 
flowing into the CI took much longer to fill up the half or more of the impactor internal volume that in the previous 
case had been almost instantaneously filled. This delay decreased as the target flow rate was increased. 
Regardless of the presence or absence of the surrogate device, the smallest values of the acceleration parameter 
were associated with configurations having the largest internal dead volumes and highest intrinsic apparatus 
resistance, an intuitive outcome. A simple two-compartment first-order model aiming to qualitatively interpret these 
and other observed effects, has been presented at this conference 4. 
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